Basal cell nevus syndrome (BCNS), which is also known as nevoid basal cell carcinoma, Gorlin’s syndrome, and MIM 109400 (Mendelian Inheritance in Man), is an autosomal dominant genodermatosis characterized mainly by the presence of multiple basal cell carcinomas (BCCs), jaw cysts, and palmoplantar pits.1 It was first described by Jarish and White in 1894,1 but its syndromic nature was not defined until 1960 by Gorlin and Goltz.2 The PTCH 1 gene, the human homologue of the Drosophila patched polarity gene, has been shown to be involved in the development of BCNS3–5 with some cases appearing as spontaneous mutations of the same gene.6 In this article we describe three sisters of different ages with an almost exactly identical presentation. Their main complaint was multiple skin tag-like papules on the skin.
Case 1
A 10-year-old girl presented to the dermatology clinic with a complaint of an increasing number of skin tags since the age of 4 (Figure 1, 2). Many dermatologists had seen her and the condition was misdiagnosed as skin tags, warts, and nevi. No skin biopsy had been done before from the skin tags. The medical history revealed hydrocephalus since birth for which she had undergone a shunt operation. She had borderline mental retardation with learning disability; she was still in the first grade. Physical examination showed multiple skin-colored to brownish soft papules; some were pedunculated, located on the face, neck, trunk, axillae and extremities. She had multiple small 0.5–1 mm palmoplantar pits. She also had characteristic phenotypic abnormalities: macrocephaly, bossing of the skull, a broad nasal root, ocular hypertelorism, scleral melanocytosis, high arched palate, uplifting of the nose, and narrow sloping shoulders. Other aspects of the physical examination were unremarkable. Radiological examination of the skull revealed hydrocephalus, calcification of the falx cerebri in addition to the ventriculoperitoneal shunt tube. X-ray of the hands revealed shortening of the fourth metacarpal bone. Other aspects of the radiographic survey were unremarkable. Panoramic x-ray of the mandible revealed no jaw cysts. A skin biopsy found follicular basal cell carcinoma (BCC) (Figure 3).
Figure 1.
Case 1 showing characteristic phenotype with bossing of the skull, hypertelorism, broad nasal root, up-lifting of the nose, and a few dark brown skin tag-like lesions on the face and neck.
Figure 2.
Same case with multiple dark brown skin tag-like papules on the back.
Figure 3.
(a,b) Basal cell carcinoma, follicular type from Case 1. (Hematoxylin-eosin stain)
The patient was treated by snipping off those pedunculated lesions followed by cryotherapy to the base to minimize scarring. In addition, the patient was provided with photoprotection and genetic counseling.
Cases 2 and 3
An 8-year-old sister of the patient described in case 1 presented in exactly the same way with skin tags, hydrocephalus, a shunt operation, characteristic facies and palmoplantar pits. She was dropped from school because of poor performance. A 6-year-old sister of the previous 2 patients, presented with only multiple skin tags and palmoplantar pits. There was no hydrocephalus yet she had a characteristic facies as well. Cases 2 and 3 did not come back for further investigation. The parents were first-degree relatives, but there were no similar problems in them or in their families.
DISCUSSION
BCNS is a genodermatosis transmitted as an autosomal dominant trait exhibiting high penetrance and variable expressivity, mapped to chromosome 9q22.3-31.7,8 Inherited or spontaneous mutations in the human homologue of the Drosophila patched gene underlie the disorder.7 The diagnosis of BCNS relies mostly on the clinical features. Table 1 summarizes both major and minor features of this syndrome.9 For diagnosis we need at least two major features, or one major feature and an affected first-degree relative or two minor features and an affected first-degree relative, or multiple BCCs in childhood.6,10,11
Table 1.
| Major features |
|---|
|
| Minor features |
|
The main complaint of the patients was the presence of multiple skin tag-like papules that were increasing in number. Skin tags are benign fibroepithelial polyps and are distinctly uncommon in this age group. Our cases developed many of the features of this syndrome early in life, with hydrocephalus, characteristic facie, palmoplantar pits, and skin tag-like lesions being among the early manifestations. Despite the fact that they were not twins, they developed almost exactly the same features. Nomland described skin tags in association with this syndrome and used the term “nevus of basal cell”.12 Elvira Chiritescu et al described 7 children with the same presentation. Multiple skin tags in this age group could represent an early sign for BCNS.11 The first case also had scleral melanocytosis, which had not been reported before with BCNS; whether it is part of the syndrome or just an isolated finding is not known.
BCCs develop much more in sun-exposed areas,13,14 especially the head and neck. Thus, a high index of suspicion and early detection of this syndrome could help in the proper management of those cases. Early use of sunscreen could decrease the number of BCCs and/or prevent aggressive growth.
Patients with BCNS should be followed closely and therapy must be directed at the individual lesions as they arise, most importantly tumors. BCCs could be treated with different modalities, cryotherapy being the least scarring. Delta-aminolevulinic acid and blue light photodynamic therapy and 5-aminolevulinic acid photodynamic therapy were reported to be successful in the treatment of multiple BCCs in BCNS with an excellent cosmetic outcome.15,16 Other modalities of treatment include electrocautery, excisions, topical imiquimod, 17 and CO2 laser resurfacing.18 Genetic counseling is important as the disease is autosomal dominant and any child of an affected family is at 50% risk of carrying the affected gene and developing the disease.19–22 In conclusion, we need to have a high index of suspension to diagnose these rare syndromes as early diagnosis and genetic counseling could prevent major consequences.
REFERENCES
- 1.Howell JB, Caro MR. The Basal-Cell Nevus: Its relationship to multiple cutaneous cancers and associated anomalies of development. Arch Dermatol. 1959;79:67–80. doi: 10.1001/archderm.1959.01560130069008. [DOI] [PubMed] [Google Scholar]
- 2.Gorlin RJ. Nevoid Basal Cell Carcinoma Syndrome. Medicine. 1987;66:98–113. doi: 10.1097/00005792-198703000-00002. [DOI] [PubMed] [Google Scholar]
- 3.Hahn H, Wicking C, Zaphiropoulos PG, Gailani MR, Shanley S, Chidambaram A, et al. Mutations of the human homologue of Drosophila Patched in the Nevoid Basal Cell Carcinoma Syndrome. Cell. 1996;85:841. doi: 10.1016/s0092-8674(00)81268-4. [DOI] [PubMed] [Google Scholar]
- 4.Johnson RL, Rothman AL, Xie J, Goodrich LV, Bare JW, Bonifas JM, et al. Human homologue of Patched, a candidate gene for the Basal Cell Nevus Syndrome. Science. 1996;272:1668. doi: 10.1126/science.272.5268.1668. [DOI] [PubMed] [Google Scholar]
- 5.Wolter M, Reifenberger J, Sommer C, Ruzicka T, Reifenberger G. Mutations in the human homologue of the Drosophila segment polarity gene patched (PTCH) in sporadic basal cell carcinoma of the skin and primitive neuroectodermal tumors of the central nervous system. Cancer Res. 1997;57:2581–2585. [PubMed] [Google Scholar]
- 6.Shanley S, Ratcliffe J, Hockey A, Haan E, Oley C, Ravine D, et al. Nevoid Basal Cell Carcinoma Syndrome: review of 118 affected individuals. Am J Med Genet. 1994;50:282–90. doi: 10.1002/ajmg.1320500312. [DOI] [PubMed] [Google Scholar]
- 7.High A, Zedan W. Basal Cell Nevus Syndrome. Curr Opin Oncol. 2005 Mar;17(2):160–166. doi: 10.1097/01.cco.0000154108.99236.ed. [DOI] [PubMed] [Google Scholar]
- 8.Unden AB, Stahle-Backdahl M, Holmberg E, Larsson C, Toftgard R. The mapping of the locus for nevoid basal cell carcinoma syndrome on chromosome 9q. Acta Derm Venereol. 1997;77:4–9. doi: 10.2340/0001555577004009. [DOI] [PubMed] [Google Scholar]
- 9.Crawford Capt Kevin M, MD, Kobayashi Maj Todd., MD Nevoid basal cell carcinoma syndrome or multiple hereditary infundibulocystic basal cell carcinoma syndrome. J Am Acad Dermatol. 2004;51:989–995. doi: 10.1016/j.jaad.2004.07.017. [DOI] [PubMed] [Google Scholar]
- 10.Kimonis VE, Goldstein AM, Pastakia B, Yang ML, Kaas R, DiGiovanna JJ, et al. Clinical Manifestations in 105 persons with nevoid basal cell carcinoma syndrome. Am J Med Genet. 1997;69:299–308. [PubMed] [Google Scholar]
- 11.Chiritescu E, Maloney ME. Acrocordons as a presenting sign of nevoid basal cell carcinoma syndrome. J Am Acad Dermatol. 2001;44:789–794. doi: 10.1067/mjd.2001.112399. [DOI] [PubMed] [Google Scholar]
- 12.Nomland R. Multiple basal cell epithelioma originating from congenital pigmented basal cell nevi. Arch Dermatol Syphilol. 1932;25:1002–1008. [Google Scholar]
- 13.Howell JB. Nevoid basal cell carcinoma syndrome: Profile of genetic & environmental factors in oncogenesis. J Am Acad Dermatol. 1984;11:98–104. doi: 10.1016/s0190-9622(84)70141-1. [DOI] [PubMed] [Google Scholar]
- 14.Goldstein AM, Bale SJ, Peck GL, DiGiovanna JJ. Sun exposure and basal cell carcinomas in the nevoid basal cell carcinoma syndrome. J Am Acad Dermatol. 1993 Jul;29(1):34–41. doi: 10.1016/0190-9622(93)70148-m. [DOI] [PubMed] [Google Scholar]
- 15.Itkin A, Gilchrest BA. Delta-Aminolevulinic acid and blue light photodynamic therapy for treatment of multiple basal cell carcinoma in two patients with nevoid basal cell carcinoma syndrome. Dermatol Surg. 2004 Jul;30(7):1054–1061. doi: 10.1111/j.1524-4725.2004.30317.x. [DOI] [PubMed] [Google Scholar]
- 16.Oseroff AR, Shieh S, Frawley NP, Cheney R, Blumenson LE, Pivnick EK, Bellnier DA. Treatment of diffuse basal cell carcinomas and basaloid follicular hamartomas in nevoid basal cell carcinoma syndrome by wide-area 5-aminolevulinic acid photodynamic therapy. Arch Dermatol. 2005 Jan;141(1):60–67. doi: 10.1001/archderm.141.1.60. [DOI] [PubMed] [Google Scholar]
- 17.Vereecken P, Monsieur E, Petein M, Heenen M. Topical application of imiquimod for the treatment of high-risk facial basal cell carcinoma in Gorlin Syndrome. J Dermatolg Treat. 2004 Apr;15(2):120–121. doi: 10.1080/09546630310017825. [DOI] [PubMed] [Google Scholar]
- 18.Doctoroff A, Oberlender SA, Purcell SM. Fullface carbon dioxide laser resurfacing in the management of a patient with the nevoid basal cell carcinoma syndrome. Dermatol Surg. 2003 Dec;29(12):1236–1240. doi: 10.1111/j.1524-4725.2003.29395.x. [DOI] [PubMed] [Google Scholar]
- 19.Chung CH, Wong TW, Shieh TY, Shieh DB, Chao SC. Nevoid Basal Cell Carcinoma Syndrome clinical manifestations & mutation analysis of a Taiwanese family. J Formos Med Assoc. 2003 Nov;102(11):793–797. [PubMed] [Google Scholar]
- 20.Petrikovsky BM, Bialer MG, McLaughlin JA, Bale AE. Sonographic and DNA-Based prenatal detection of Gorlin Syndrome. J Ultrasound Med. 1996 Jun;15(6):493–495. doi: 10.7863/jum.1996.15.6.493. [DOI] [PubMed] [Google Scholar]
- 21.Bialer MG, Gailani MR, McLaughlin JA, Petrikovsky B, Bale AE. Prenatal diagnosis of Gorlin Syndrome. Lancet. 1994 Aug;13:344. doi: 10.1016/s0140-6736(94)91810-4. [DOI] [PubMed] [Google Scholar]
- 22.Hogge WA, Blank C, Roochvarg LB, Hogge JS, Wulfsberg FA, Raffel LJ. Gorlin Syndrome (nevoid basal cell carcinoma syndrome): Prenatal detection in a fetus with macrocephaly and ventriculomegaly. Prenat Diagn. 1994 Aug;14(8):725–727. doi: 10.1002/pd.1970140813. [DOI] [PubMed] [Google Scholar]



